Pharmacokinetic and pharmacodynamic evaluation of RH1 during a phase I clinical trial.

被引：0
|
作者：
Ward, TH
Danson, S
Dawson, M
McGrath, H
Denneny, O
Cummings, J
Dive, C
Ranson, M
机构：
[1] Christie Hosp NHS Trust, Paterson Inst Canc Res, Manchester M20 4BX, Lancs, England
[2] Christie Hosp NHS Trust, Dept Med Oncol, Manchester M20 4BX, Lancs, England
[3] Canc Res UK, Drug Dev Off, London, England
来源：
BRITISH JOURNAL OF CANCER | 2004年 / 91卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
下载
收藏
页码：S60 / S60
页数：1
相关论文
共 50 条
  • [41] Nintedanib plus letrozole in early breast cancer: a phase 0/I pharmacodynamic, pharmacokinetic, and safety clinical trial of combined FGFR1 and aromatase inhibition
    Miguel Quintela-Fandino
    Juan V. Apala
    Diego Malon
    Silvana Mouron
    Javier Hornedo
    Lucia Gonzalez-Cortijo
    Ramon Colomer
    Juan Guerra
    Breast Cancer Research, 21
  • [42] Prolonged infusion of gemcitabine: Clinical and pharmacodynamic studies during a phase I trial in relapsed acute myelogenous leukemia
    Gandhi, V
    Plunkett, W
    Du, M
    Ayres, M
    Estey, EH
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (03) : 665 - 673
  • [43] Imaging dopamine transporters with I-123 altropane: Preliminary report of a phase 1 clinical trial.
    Mercier, G
    Pourdehnad, M
    Alavi, A
    Reivich, M
    Mozley, D
    Fischman, A
    Lanser, M
    JOURNAL OF NUCLEAR MEDICINE, 1998, 39 (05) : 214P - 214P
  • [44] Phase I clinical trial of the novel platin complex dicycloplatin: clinical and pharmacokinetic results
    Li, Su
    Huang, He
    Liao, Hai
    Zhan, Jing
    Guo, Yin
    Zou, Ben-yan
    Jiang, Wen-qi
    Guan, Zhong-zhen
    Yang, Xu-qing
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2013, 51 (02) : 96 - 105
  • [45] A population pharmacokinetic and pharmacokinetic-pharmacodynamic analysis of vupanorsen from phase I and phase II studies
    Ahn, Jae Eun
    Terra, Steven G.
    Liu, Jing
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2023, 12 (07): : 988 - 1000
  • [46] CHARACTERIZATION OF PHARMACOKINETIC PROFILES AND METABOLIC PATHWAYS OF 20(S)-GINSENOSIDE RH1 IN VIVO AND IN VITRO
    Lai, Li
    Hao, Haiping
    Wang, Guangji
    Chen, Xijing
    Liu, Yitong
    DRUG METABOLISM REVIEWS, 2008, 40 : 144 - 145
  • [47] Pharmacokinetic and pharmacodynamic properties of docetaxel: Results of phase I and phase II trials
    Bruno, R
    Riva, A
    Hille, D
    Lebecq, A
    Thomas, L
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1997, 54 : S16 - S19
  • [48] Characterization of Pharmacokinetic Profiles and Metabolic Pathways of 20(S)-Ginsenoside Rh1 in vivo and in vitro
    Lai, Li
    Hao, Haiping
    Liu, Yitong
    Zheng, Chaonan
    Wang, Qiong
    Wang, Guangji
    Chen, Xijin
    PLANTA MEDICA, 2009, 75 (08) : 797 - 802
  • [49] PHASE-I STUDY OF INTRAPERITONEAL MITOXANTRONE CLINICAL AND PHARMACOKINETIC EVALUATION
    BLOCHLDAUM, B
    EICHLER, HG
    RAINER, H
    JAKESZ, R
    SALZER, H
    STEGER, G
    SCHULLER, J
    GUNTHER, E
    PROKSCH, P
    EHNINGER, G
    ONKOLOGIE, 1987, 10 (01): : 54 - 56
  • [50] Trimethoprim/sulfametrole: evaluation of the available clinical and pharmacokinetic/pharmacodynamic evidence
    Vouloumanou, Evridiki K.
    Karageorgopoulos, Drosos E.
    Rafailidis, Petros I.
    Michalopoulos, Argyris
    Falagas, Matthew E.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2011, 38 (03) : 197 - 216
12345